Gray Matter Volume Reduction Is Associated with Cognitive Impairment in Neuromyelitis Optica (Q48741514)

15 February 2018

title

Gray Matter Volume Reduction Is Associated with Cognitive Impairment in Neuromyelitis Optica (English)

1 reference

15 February 2018

main subject

cognitive dysfunction

1 reference

Q Wang

1 reference

15 February 2018

N Zhang

1 reference

15 February 2018

W Qin

1 reference

15 February 2018

Y Li

1 reference

15 February 2018

Y Fu

1 reference

15 February 2018

T Li

1 reference

15 February 2018

J Shao

1 reference

15 February 2018

L Yang

1 reference

15 February 2018

F-D Shi

1 reference

15 February 2018

C Yu

1 reference

15 February 2018

publication date

3 September 2015

1 reference

15 February 2018

American Journal of Neuroradiology

published in

1 reference

15 February 2018

volume

1 reference

15 February 2018

issue

1 reference

15 February 2018

page(s)

1822-1829

1 reference

15 February 2018

Revised diagnostic criteria for neuromyelitis optica

cites work

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

The spectrum of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

The clinical course of neuromyelitis optica (Devic's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Brain abnormalities in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Conventional and advanced imaging in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Regional homogeneity changes in patients with neuromyelitis optica revealed by resting-state functional MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Abnormal baseline brain activity in patients with neuromyelitis optica: a resting-state fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Cognitive impairment and whole brain diffusion in patients with neuromyelitis optica after acute relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

White matter volume is decreased in the brain of patients with neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Cortical thinning correlates with cognitive change in multiple sclerosis but not in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

White matter atrophy and cognitive dysfunctions in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

White matter atrophy in brain of neuromyelitis optica: a voxel-based morphometry study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

No MRI evidence of cortical lesions in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Cognitive functions in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Cognitive function, depression, fatigue, and activities of daily living in patients with neuromyelitis optica after acute relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Cognitive impairment and cortical degeneration in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Cognitive profile in patients with a first-ever lacunar infarct with and without silent lacunes: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

A fast diffeomorphic image registration algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Aquaporin 4 and neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Neuromyelitis optica spectrum disorders associated with other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Absence of cortical demyelination in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Cognitive functions in multiple sclerosis: impact of gray matter integrity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Multiple sclerosis: altered thalamic resting-state functional connectivity and its effect on cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4403

21 January 2018

Identifiers

DOI

10.3174/AJNR.A4403

1 reference

15 February 2018

1 reference

15 February 2018